Protagen has a number of established and committed investors, but is always looking at entering into new partnerships to help progress its research and commercialization efforts. If you are interested in investing in the company, please contact us.

Here you can find out more about our group of committed long-term investors.


Current investors & shareholders:

Get in touch

Improving the treatment of cancer and autoimmune disease is our passion, and we always welcome the chance to discuss these topics with current and prospective customers, patients and clinicians alike.

1 + 15 =

Copyright © 1997-2018
Protagen AGDortmund, Germany